Abstract:Carbohydrate Response Element-Binding Protein (ChREBP) is a transcription factor that activates key genes involved in glucose, fructose, and lipid metabolism in response to carbohydrate feeding, but its other potential roles in metabolic homeostasis have not been as well studied. We used liver-selective GalNAc-siRNA technology to suppress expression of ChREBP in rats fed a high fat/high sucrose diet and characterized hepatic and systemic responses by integrating transcriptomic and metabolomic analyses. GalNAc-siChREBP-treated rats had lower levels of multiple short-chain acyl CoA metabolites compared to rats treated with GalNAc-siCtrl containing a non-targeting siRNA sequence. These changes were related to a sharp decrease in free CoA levels in GalNAc-siChREBP treated-rats, accompanied by lower expression of transcripts encoding enzymes and transporters involved in CoA biosynthesis. These activities of ChREBP likely contribute to its complex effects on hepatic lipid and energy metabolism. While core enzymes of fatty acid (FA) oxidation are induced by ChREBP knockdown, accumulation of liver acylcarnitines and circulating ketones indicate diversion of acetyl CoA to ketone production rather than complete oxidation in the TCA cycle. Despite strong suppression of pyruvate kinase and activation of pyruvate dehydrogenase, pyruvate levels were maintained, likely via increased expression of pyruvate transporters, and decreased expression of lactate dehydrogenase and alanine transaminase. GalNAc-siChREBP treatment increased hepatic citrate and isocitrate levels while decreasing levels of distal TCA cycle intermediates. The drop in free CoA levels, needed for the 2-ketoglutarate dehydrogenase reaction, as well as a decrease in transcripts encoding the anaplerotic enzymes pyruvate carboxylase, glutamate dehydrogenase, and aspartate transaminase likely contributed to these effects. GalNAc-siChREBP treatment caused striking increases in PRPP and ZMP/AICAR levels, and decreases in GMP, IMP, AMP, NaNM, NAD(P), and NAD(P)H levels, accompanied by reduced expression of enzymes that catalyze late steps in purine and NAD synthesis. ChREBP suppression also increased expression of a set of plasma membrane amino acid transporters, possibly as an attempt to replenish TCA cycle intermediates. In sum, combining transcriptomic and metabolomic analyses has revealed regulatory functions of ChREBP that go well beyond its canonical roles in control of carbohydrate and lipid metabolism to now include mitochondrial metabolism and cellular energy balance.

Flightless I Homolog Negatively Regulates ChREBP Activity in Cancer Cells.

Data from Flightless I Homolog Represses Prostate Cancer Progression Through Targeting Androgen Receptor Signaling

The Flightless I Protein Interacts with RNA-binding Proteins and is Involved in the Genome-Wide Mrna Post-Transcriptional Regulation in Lung Carcinoma Cells.

Identification of cis-regulatory elements and trans-acting proteins of the rat carbohydrate response element binding protein gene.

Identification of HNF-4α As a Key Transcription Factor to Promote ChREBP Expression in Response to Glucose

Tumor-suppressive Functions of Leucine Zipper Transcription Factor-Like 1.

Lipogenic Transcription Factor ChREBP Mediates Fructose-Induced Metabolic Adaptations to Prevent Hepatotoxicity

ChREBP Promotes the Differentiation of Leukemia-Initiating Cells to Inhibit Leukemogenesis Through the TXNIP/RUNX1 Pathways

The Ubiquitination Ligase SMURF2 Reduces Aerobic Glycolysis and Colorectal Cancer Cell Proliferation by Promoting ChREBP Ubiquitination and Degradation.

CHREBP Suppresses Gastric Cancer Progression Via the Cyclin D1-Rb-E2F1 Pathway

The Glucose-Responsive Transcription Factor ChREBP Contributes to Glucose-Dependent Anabolic Synthesis and Cell Proliferation

Integration of metabolomic and transcriptomic analyses reveals novel regulatory functions of the ChREBP transcription factor in energy metabolism

ChREBP regulates fructose-induced glucose production independently of insulin signaling

Chac2, Downregulated in Gastric and Colorectal Cancers, Acted As A Tumor Suppressor Inducing Apoptosis and Autophagy Through Unfolded Protein Response

Glucose-induced and ChREBP: MLX-mediated lipogenic program promotes hepatocellular carcinoma development

ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue

Tissue Specific Effects of Dietary Carbohydrates and Obesity on ChREBPα and ChREBPβ Expression

ChREBP- regulates thermogenesis in brown adipose tissue

ERα Down‐regulates Carbohydrate Responsive Element Binding Protein and Decreases Aerobic Glycolysis in Liver Cancer Cells

The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolism

FLI-1 mediates tumor suppressor function via Klotho signaling in regulating CRC